Combination therapy in hypertension: An update
نویسندگان
چکیده
منابع مشابه
Combination therapy in hypertension: An update
Meticulous control of blood pressure is required in patients with hypertension to produce the maximum reduction in clinical cardiovascular end points, especially in patients with comorbidities like diabetes mellitus where more aggressive blood pressure lowering might be beneficial. Recent clinical trials suggest that the approach of using monotherapy for the control of hypertension is not likel...
متن کاملCombination Therapy in Managing Hypertension-An Overview
Hypertension is a condition that involves multiple body organs and physiological systems. Maintaining blood pressure (BP) by using one class of drugs that affect one or two systems usually have inadequate response and result in a compensatory or counter-regulatory response from others to blunt the targeted effect of individual drug. For example, starting with diuretics result in initially decre...
متن کاملCombination therapy in hypertension.
The goal of antihypertensive therapy is to abolish the risks associated with blood pressure (BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy in lowering BP and in reducing cardiovascular (CV) end points including stroke, myocardial infarction, and heart failure. Although the choice of initial drug therapy exerts some effect on long-term outcomes, i...
متن کاملCombination therapy for hypertension.
Hypertension affects more than one tenth of the adult population in Hong Kong. In fact, using the latest recommended cut-off points for systolic blood pressure of 140 mm Hg and diastolic blood pressure of 90 mm Hg, the prevalence of hypertension in Hong Kong adults is close to 20%. The apparent increase in the prevalence of hypertension in recent years is largely due to increased recognition of...
متن کاملTherapy of pulmonary arterial hypertension in systemic sclerosis: an update.
Pulmonary arterial hypertension (PAH) affects 10% to 15% of patients with systemic sclerosis and is a major cause for disease-related morbidity and mortality. Over the past decade, significant progress has been made in the understanding of the pathophysiologic mechanisms underlying PAH. This progress led to the development of several new treatment options and, as a result, dramatically improved...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetology & Metabolic Syndrome
سال: 2010
ISSN: 1758-5996
DOI: 10.1186/1758-5996-2-44